First patient treated in landmark transcatheter mitral valve replacement pivotal trial
Medtronic announced the first patient implant in the APOLLO Trial - the pivotal trial designed to evaluate the Intrepid(TM) TMVR system following receipt of an IDE from the FDA. The study will evaluate afety and efficacy of the Intrepid TMVR system in up to 1,200 patients. October 23, 2017